Lumida
/EMR
⌘K
Emerson Electric Co

Emerson Electric Co

EMR
$139.54USD+0.33%+0.46 today

MARKET CAP

78.2B

P/E (TTM)

22.7x

FWD P/E

19.8x

DAY RANGE

$138 – $142

52W RANGE

$123
$165

AI Summary

Stalk
TrimMedium

EMR is in a Stage 4 decline with medium-term bearish bias following a recent support failure. The loss of a key horizontal support zone coupled with selling into the moving averages confirms downward momentum. Price now hovers at a resistance confluence of the fallen support and EMAs, making rallies into this zone optimal for bearish engagement. Overall execution favors trimming into strength as supply remains dominant.

  • Q2 underlying orders +5% YoY underpinned fiscal EPS guide $6.45–$6.55
  • Q2 FCF $694M (15% margin) funded $542M buybacks and $1.2B dividends
  • Negative earnings yield and weak profitability signal valuation headwinds
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

Emerson Electric Co. (NYSE: EMR) is a leading global technology and engineering company focused on automation solutions and commercial & residential solutions. Positioned at the forefront of the industrial automation landscape, Emerson provides innovative solutions that enhance operational efficiency, reliability, and safety in various sectors, including the power generation, life sciences, and energy management industries. The company's ongoing investment in software technologies, particularly in artificial intelligence, positions it favorably within the broader themes of automation and energy transition.

Bull says

  • Q2 underlying orders +5% YoY underpinned fiscal EPS guide $6.45–$6.55
  • Q2 FCF $694M (15% margin) funded $542M buybacks and $1.2B dividends
  • Backlog grew 9% YoY to $8.2B, bolstering project pipeline
  • Software revenue expected +8% Q3, driven by AI automation demand
  • Institutional 13F ownership positive, signaling broad investor confidence
  • AI and automation investments position Emerson for energy transition gains

Bear says

  • Negative earnings yield and weak profitability signal valuation headwinds
  • Growth factor down, analyst revisions indicate sliding revenue outlook
  • Middle East tensions and China slowdown risk order momentum
  • Software renewals pressured revenue by ~1 ppt this quarter
  • Short interest high, amplifying downside amid weak sentiment
  • Elevated leverage risk could exacerbate margin pressure if growth stalls

Investment themes with EMR

High Dividend Yield +0.32%

Companies paying above-average dividends

AVGO · JPM · XOM
High Beta -0.12%

Stocks with high volatility relative to market

AMD · DELL · MPWR
Infrastructure Development +0.48%

DE · HWM · TT

Earnings Call · Q2 2026 · Mgmt. Guidance

Updated 05-08-2026neutral

Transcript signals

Bull points

  • Underlying orders grew 5% in the second quarter, led by software and systems, which saw robust investment in our growth verticals and sustained momentum in North America and India.
  • Adjusted segment EBITDA margin of 27.6% exceeded expectations, and we delivered adjusted earnings per share of $1.54 near the top end of our guidance.
  • We remain confident in our second half plans for 2026 based on the orders momentum we are seeing and the visibility we have from our backlog, which is up 9% year over year.

Bear points

  • Underlying sales growth of a half percent was below expectations due to a one-point impact from the Middle East conflict.
  • We are updating our full-year guidance to reflect the impact of the conflict in the Middle East, and we now expect sales growth of 4.5% with underlying growth of 3%.
  • The conflict presented a significant disruption in the quarter, causing a one-point impact to underlying sales.
Read full transcript analysis ›